Meta Biomed Toekomstige groei
Future criteriumcontroles 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Meta Biomed.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
Medical Equipment winstgroei | 33.5% |
Inkomstengroei | n/a |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | None |
Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Geen updates
Recent updates
Earnings Tell The Story For Meta Biomed Co., Ltd. (KOSDAQ:059210) As Its Stock Soars 30%
Feb 26Here's How We Evaluate Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Dividend
Apr 11Meta Biomed's (KOSDAQ:059210) Stock Price Has Reduced 58% In The Past Five Years
Mar 14Are Meta Biomed's (KOSDAQ:059210) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 21Can Meta Biomed (KOSDAQ:059210) Continue To Grow Its Returns On Capital?
Feb 03Is Meta Biomed (KOSDAQ:059210) A Risky Investment?
Jan 13Here's Why I Think Meta Biomed (KOSDAQ:059210) Is An Interesting Stock
Dec 26Meta Biomed (KOSDAQ:059210) Share Prices Have Dropped 22% In The Last Five Years
Dec 08Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 20In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Meta Biomed onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
6/30/2024 | 90,091 | 14,734 | 5,937 | 18,952 | N/A |
3/31/2024 | 84,438 | 12,309 | 75 | 15,118 | N/A |
12/31/2023 | 83,101 | 10,292 | -1,277 | 10,217 | N/A |
9/30/2023 | 79,545 | 6,787 | -6,241 | 9,632 | N/A |
6/30/2023 | 77,747 | 3,141 | -10,070 | 7,265 | N/A |
3/31/2023 | 75,428 | 4,645 | -1,964 | 5,952 | N/A |
12/31/2022 | 68,942 | 1,874 | -6,150 | 9,159 | N/A |
9/30/2022 | 66,883 | 7,127 | 1,072 | 10,295 | N/A |
6/30/2022 | 61,372 | 8,604 | 5,793 | 11,763 | N/A |
3/31/2022 | 60,795 | 8,832 | 1,934 | 14,655 | N/A |
12/31/2021 | 58,780 | 9,381 | 9,036 | 11,136 | N/A |
9/30/2021 | 54,183 | 4,490 | 7,356 | 9,437 | N/A |
6/30/2021 | 51,861 | 4,196 | 5,672 | 7,628 | N/A |
3/31/2021 | 45,793 | -1,093 | 1,638 | 3,950 | N/A |
12/31/2020 | 44,998 | -3,091 | 1,810 | 4,862 | N/A |
9/30/2020 | 46,823 | 2,035 | 227 | 4,486 | N/A |
6/30/2020 | 49,075 | 1,980 | -4,191 | 1,810 | N/A |
3/31/2020 | 56,034 | 5,445 | -5,291 | 1,411 | N/A |
12/31/2019 | 59,391 | 5,527 | -5,204 | 2,865 | N/A |
9/30/2019 | 52,268 | 156 | -5,122 | 2,248 | N/A |
6/30/2019 | 53,192 | 64 | -28,883 | -20,263 | N/A |
3/31/2019 | 51,518 | -1,435 | -8,893 | -1,167 | N/A |
12/31/2018 | 52,586 | 953 | -16,163 | -5,283 | N/A |
9/30/2018 | 64,158 | -4,131 | -24,772 | -8,173 | N/A |
6/30/2018 | 65,530 | -2,666 | -1,417 | 14,076 | N/A |
3/31/2018 | 66,563 | -2,753 | N/A | -3,204 | N/A |
12/31/2017 | 65,341 | -4,104 | N/A | -249 | N/A |
9/30/2017 | 66,531 | 262 | N/A | 3,853 | N/A |
6/30/2017 | 64,329 | -635 | N/A | 6,498 | N/A |
3/31/2017 | 64,383 | 761 | N/A | 6,642 | N/A |
12/31/2016 | 65,784 | 639 | N/A | 5,033 | N/A |
9/30/2016 | 65,639 | 2,240 | N/A | 4,703 | N/A |
6/30/2016 | 67,236 | 1,476 | N/A | 2,429 | N/A |
3/31/2016 | 68,227 | 322 | N/A | 2,279 | N/A |
12/31/2015 | 68,592 | 806 | N/A | 4,933 | N/A |
9/30/2015 | 67,332 | -2,369 | N/A | 2,626 | N/A |
6/30/2015 | 66,230 | -3,088 | N/A | 964 | N/A |
3/31/2015 | 63,748 | -4,242 | N/A | 962 | N/A |
12/31/2014 | 61,365 | -4,952 | N/A | -296 | N/A |
9/30/2014 | 58,403 | -1,117 | N/A | 1,496 | N/A |
6/30/2014 | 59,885 | -619 | N/A | 3,648 | N/A |
3/31/2014 | 63,423 | 1,752 | N/A | 4,627 | N/A |
12/31/2013 | 63,518 | 1,967 | N/A | 3,712 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if A059210's forecast earnings growth is above the savings rate (2.6%).
Winst versus markt: Insufficient data to determine if A059210's earnings are forecast to grow faster than the KR market
Hoge groeiwinsten: Insufficient data to determine if A059210's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if A059210's revenue is forecast to grow faster than the KR market.
Hoge groei-inkomsten: Insufficient data to determine if A059210's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if A059210's Return on Equity is forecast to be high in 3 years time